Abstract
The treatment goal for patients with faecal incontinence is to eliminate or decrease the number of involuntary passages of faeces. Numerous causes for the symptom of faecal incontinence are recognised suggesting successful treatment approaches will vary. Medical management is limited since few drugs have been shown to alter the symptoms or the observable abnormalities in patients with faecal incontinence. It seems unlikely that medical treatment can be effective for patients with irreversible muscle and nerve damage, which has been reported to be present in as high as 80% of the cases of faecal incontinence [1]. Rational treatment is limited further by the imprecise understanding of the complex process of voluntary defaecation and continence. Until proper studies provide sufficient information to direct drugs at specific and treatable abnormalities, medical management will consist of partial treatment of some of the factors involved in the continence mechanism or in designing a program of planned defaecation to avoid incontinent episodes.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Swash M. 1985. New concepts in incontinence. Br Med J 290: 4–5.
Read NW, Harford WV, Schmulen AC, Read MG, Santa-Ana C, Fordtran JS. 1979. A clinical study of patients with faecal incontinence and diarrhoea. Gastroenterology 76: 745–756.
Read MG, Read NW, Barber DC, Duthie HL. 1982. Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhoea with faecal incontinence and urgency. Dig Dis Sci 27: 807–813.
Palmer KR, Corbett CL, Holdsworth CD. 1980. Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhoea. Gastroenterology 79: 1272–1275.
Harford WV, Krejs GJ, Santa-Ana CA, Fordtran JS. 1980. Acute effect of diphenoxylate with atropine (Lomotil) in patients with chronic diarrhoea and faecal incontinence. Gastroenterology 78: 440–443.
Read NW, Haynes WG, Bartolo DCC, Hall J, Read MG, Donnelly TC, Johnson AG. 1983. Use of ano-rectal manometry during rectal infusion of saline to investigate sphincter function in incontinent patients. Gastroenterology 85:105–113.
Read NW, Bartolo DCC, Read MG. 1984. Differences in anal function in patients with incontinence to solids and in patients with incontinence to liquids. Br J Surg 71: 39–42.
Taylor I, Basu P, Hammond P, Darby C, Flynn M, 1980. Effect of bile acid perfusion on colonic motor function in patients with the irritable bowel syndrome. Gut 21: 843–847.
Thaysen EH, Pedersen L. 1976. Idiopathic bile salt catharsis. Gut 17: 965–970.
Flynn M, Darby C, Hyland J, Hammond P, Taylor I.1979. The effect of bile acids on colonic myoelectric activity. Br J Surg 66: 776–779.
Buchmann P, Kolb E, Alexander-Williams J. 1981. Pathogenesis of urgency in defaecation in Crohn’s disease. Digestion 22: 310–316.
Ludgate SM, Merrick MV. 1985. The pathogenesis of post-irradiation chronic diarrhoea: management of SeHCAT and B12 absorption for differential diagnosis determines treatment. Clin Radiol 36: 275–278.
Merrick MV, Eastwood MA, Ford MJ. 1985. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br Med J 290: 665–668.
Wald A. 1981. Biofeedback therapy for faecal incontinence. Ann Int Med 95:146–149.
Guttmann L. 1976. Spinal Cord Injuries - Comprehensive Management and Research. Second Edition. Oxford. Blackwell Scientific Publications.
Wald A. 1983. Biofeedback for neurogenic faecal incontinence: rectal sensation is a determinant of outcome. J Pediatr Gastroenterol Nutr 2: 302–306.
Burleigh DE, D’Mello A, Parks AG. 1979. Responses of isolated human internal anal sphincter to drugs and electrical field stimulation. Gastroenterology 77: 484–490.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Miner, P.B. (1987). Medical treatment. In: Gooszen, H.G., Ten Cate Hoedemaker, H.O., Weterman, I.T., Keighley, M.R.B. (eds) Disordered Defaecation. Developments In Surgery, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3335-4_14
Download citation
DOI: https://doi.org/10.1007/978-94-009-3335-4_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7998-3
Online ISBN: 978-94-009-3335-4
eBook Packages: Springer Book Archive